Conrad A. Vink

599 total citations
15 papers, 417 citations indexed

About

Conrad A. Vink is a scholar working on Molecular Biology, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Conrad A. Vink has authored 15 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Genetics and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Conrad A. Vink's work include Virus-based gene therapy research (13 papers), CRISPR and Genetic Engineering (9 papers) and RNA Interference and Gene Delivery (7 papers). Conrad A. Vink is often cited by papers focused on Virus-based gene therapy research (13 papers), CRISPR and Genetic Engineering (9 papers) and RNA Interference and Gene Delivery (7 papers). Conrad A. Vink collaborates with scholars based in United Kingdom, Germany and South Africa. Conrad A. Vink's co-authors include Nathan P. Sweeney, Adrian J. Thrasher, Waseem Qasim, Manfred Schmidt, Richard Gabriel, John R. Counsell, Simon N. Waddington, Steven J. Howe, H. Bobby Gaspar and R. Scott McIvor and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Biomaterials.

In The Last Decade

Conrad A. Vink

15 papers receiving 410 citations

Peers

Conrad A. Vink

GENET

ONCOL

IMMUN

Natalie J Ward United Kingdom

Gaurav Backliwal Switzerland

Seung Shin Yu South Korea

Laura Vannucci Italy

Maarten Holkers Netherlands

Karim Ghani Canada

Valentina Poletti Italy

K.K. Wong United States

Sayandip Mukherjee United Kingdom

Sabine Knoess Germany

Natalie J Ward United Kingdom

Conrad A. Vink

379 ×1.1

321 ×1.4

GENET

86 ×1.0

ONCOL

37 ×0.9

IMMUN

68 ×2.0

Citations per year, relative to Conrad A. Vink Conrad A. Vink (= 1×) peers Natalie J Ward

Countries citing papers authored by Conrad A. Vink

Since Specialization

Citations

This map shows the geographic impact of Conrad A. Vink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Conrad A. Vink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Conrad A. Vink more than expected).

Fields of papers citing papers by Conrad A. Vink

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Conrad A. Vink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Conrad A. Vink. The network helps show where Conrad A. Vink may publish in the future.

Co-authorship network of co-authors of Conrad A. Vink

This figure shows the co-authorship network connecting the top 25 collaborators of Conrad A. Vink. A scholar is included among the top collaborators of Conrad A. Vink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Conrad A. Vink. Conrad A. Vink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Ficarelli, Mattia, Dorota Kmieć, Adrian W. Signell, et al.. (2021). Minimal impact of ZAP on lentiviral vector production and transduction efficiency. Molecular Therapy — Methods & Clinical Development. 23. 147–157. 2 indexed citations

Ficarelli, Mattia, et al.. (2021). HIV-1 sequences in lentiviral vector genomes can be substantially reduced without compromising transduction efficiency. Scientific Reports. 11(1). 12067–12067. 8 indexed citations

Vink, Conrad A., et al.. (2021). A novel role for gag as a cis-acting element regulating RNA structure, dimerization and packaging in HIV-1 lentiviral vectors. Nucleic Acids Research. 50(1). 430–448. 1 indexed citations

Sweeney, Nathan P. & Conrad A. Vink. (2021). The impact of lentiviral vector genome size and producer cell genomic to gag-pol mRNA ratios on packaging efficiency and titre. Molecular Therapy — Methods & Clinical Development. 21. 574–584. 49 indexed citations

Lever, Andrew, et al.. (2020). Development of a Novel Competitive qRT-PCR Assay to Measure Relative Lentiviral Packaging Efficiency. Molecular Therapy — Methods & Clinical Development. 19. 307–319. 5 indexed citations

Counsell, John R., Jinhong Meng, Conrad A. Vink, et al.. (2017). Lentiviral vectors can be used for full-length dystrophin gene therapy. Scientific Reports. 7(1). 29 indexed citations

Counsell, John R., Jinhong Meng, Conrad A. Vink, et al.. (2017). Lentiviral vectors can be used for full-length dystrophin gene therapy. Scientific Reports. 7(1). 44775–44775. 51 indexed citations

Vink, Conrad A., John R. Counsell, Dany Perocheau, et al.. (2017). Eliminating HIV-1 Packaging Sequences from Lentiviral Vector Proviruses Enhances Safety and Expedites Gene Transfer for Gene Therapy. Molecular Therapy. 25(8). 1790–1804. 27 indexed citations

Weng, Alexander, Maria Manunta, Mayank Thakur, et al.. (2015). Improved intracellular delivery of peptide- and lipid-nanoplexes by natural glycosides. Journal of Controlled Release. 206. 75–90. 27 indexed citations

10.

Counsell, John R., Conrad A. Vink, Dany Perocheau, et al.. (2015). 529. Novel LTR-1 Lentiviral Vectors Are Fully Functional Following the Removal of HIV-1 Gag-RRE Sequences. Molecular Therapy. 23. S212–S212. 1 indexed citations

11.

Tagalakis, Aristides D., Dani Do Hyang Lee, Alison Bienemann, et al.. (2014). Multifunctional, self-assembling anionic peptide-lipid nanocomplexes for targeted siRNA delivery. Biomaterials. 35(29). 8406–8415. 71 indexed citations

12.

Field, Anne-Christine, Conrad A. Vink, Richard Gabriel, et al.. (2013). Comparison of Lentiviral and Sleeping Beauty Mediated αβ T Cell Receptor Gene Transfer. PLoS ONE. 8(6). e68201–e68201. 39 indexed citations

13.

Qasim, Waseem, Conrad A. Vink, & Adrian J. Thrasher. (2010). Hybrid Lentiviral Vectors. Molecular Therapy. 18(7). 1263–1267. 10 indexed citations

14.

Vink, Conrad A., H. Bobby Gaspar, Richard Gabriel, et al.. (2009). Sleeping Beauty Transposition From Nonintegrating Lentivirus. Molecular Therapy. 17(7). 1197–1204. 62 indexed citations

15.

Vink, Conrad A., Sheena Lee, Peter Treasure, et al.. (2006). The integration profile of EIAV-based vectors. Molecular Therapy. 14(4). 536–545. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact